A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study was to explore the effectiveness and safety of early TMZ chemotherapy between
surgery and chemoradiotherapy plus the standard concomitant radiochemotherapy regimen.